{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:53:47Z","timestamp":1784685227013,"version":"3.55.0"},"reference-count":77,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.1080\/13543784.2025.2551353","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T14:20:24Z","timestamp":1756477224000},"page":"695-703","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Acute chest syndrome (ACS) in sickle cell disease (SCD): pathogenesis and pharmacotherapies in early clinical development"],"prefix":"10.1080","volume":"34","author":[{"given":"Subarna","family":"Chakravorty","sequence":"first","affiliation":[{"name":"King\u2019s College Hospital NHS Foundation Trust","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8672-5349","authenticated-orcid":false,"given":"Anne","family":"Greenough","sequence":"additional","affiliation":[{"name":"King\u2019s College London","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30193-9"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom13030413"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V33.6.884.884"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012838"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23367"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1089\/ped.2017.0814"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201111-2082CI"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.2.776.bloodjournal862776"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.2.643.643"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.5.1787"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-142968"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-024-01283-5"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/children9060894"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422502"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2023.150755"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-317315"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.07.4219"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.25141"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38817"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.11.3107.3107"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.6.2573.bloodjournal8762573"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00986.2004"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.239350"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.239343"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018021709"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003519"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00491.2010"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19561"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12445"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-361642"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.283716"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15401"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00273.2023"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64578"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-495887"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014894"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-169715"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002202.pub3"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200316672"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0708445"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-409524"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715971"},{"key":"e_1_3_4_45_1","unstructured":"Fda approved L-glutamine powder for the treatment of sickle cell disease [Internet]. 2017. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approved-l-glutamine-powder-treatment-sickle-cell-disease"},{"key":"e_1_3_4_46_1","unstructured":"European Medicines Agency. Xyndari. 2019 Jun 9."},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807023390102"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.119593"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0005-2024"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.235"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509143331104"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.9.3082"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08827.x"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-4060-2"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4397150"},{"issue":"10","key":"e_1_3_4_56_1","first-page":"363","article-title":"Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results","volume":"93","author":"Waugh WH","year":"2001","unstructured":"Waugh WH, Daeschner CW 3rd, Files BA, et al. Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results. J Natl Med Assoc. 2001 Oct;93(10):363\u2013371.","journal-title":"J Natl Med Assoc"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14110783"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202409-1727OC"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-020-00715-w"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611770"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00384-3"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1421943"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-205971"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013674"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25855"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk6129"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-203653"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-211753"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00078-4"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2400402"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284633"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2025.2500599"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2024000678"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.921432"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007645"},{"key":"e_1_3_4_76_1","unstructured":"National Institute of Clinical Excellence. Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and over: national Institute of Clinical Excellence. 2025 [cited 2025 May 26]. Available from: https:\/\/www.nice.org.uk\/guidance\/TA1044"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309676"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c02251"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-303773"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2025.2551353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:33:03Z","timestamp":1763375583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2025.2551353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":77,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"alternative-id":["10.1080\/13543784.2025.2551353"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2025.2551353","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}